Fenoterol and asthma mortality.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 2566750)

Published in Lancet on May 27, 1989

Authors

N Pearce, J Crane, C Burgess, R Beasley, R Jackson

Articles by these authors

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82

Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10

End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88

Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods (1991) 4.64

Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46

Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health (1993) 4.27

A case-control study of deaths from asthma. Thorax (1986) 3.97

Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87

Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart (2008) 3.73

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72

Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70

Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39

Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39

Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34

Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32

Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30

Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15

Myxomatosis. N Z Vet J (1985) 3.12

Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10

How much asthma is really attributable to atopy? Thorax (1999) 3.04

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02

Role of methionine in the initiation of haemoglobin synthesis. Nature (1970) 3.02

COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97

Guidelines for clinical guidelines. BMJ (1998) 2.96

World War I may have allowed the emergence of "Spanish" influenza. Lancet Infect Dis (2002) 2.88

Impact of relational coordination on quality of care, postoperative pain and functioning, and length of stay: a nine-hospital study of surgical patients. Med Care (2000) 2.87

Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81

Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76

The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65

The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61

Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61

Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54

Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53

Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52

Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax (1996) 2.46

Effect of environmental factors on risk of injury of child pedestrians by motor vehicles: a case-control study. BMJ (1995) 2.41

Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36

Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA (1976) 2.32

The lines of Blaschko: a review and reconsideration: Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol (1976) 2.28

Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27

The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27

Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25

Changing sex ratio in the United States, 1969-1995. Fertil Steril (1998) 2.23

Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19

Passive smoking and passive thinking. N Z Med J (1989) 2.17

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15

Guidelines on preventing cardiovascular disease in clinical practice. BMJ (2000) 2.15

Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06

Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med (1990) 2.04

Baseline risk for asthma deaths. N Z Med J (1992) 2.02

Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med (1994) 2.01

Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions. Heart (2008) 2.00

Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99

The role of driver sleepiness in car crashes: a systematic review of epidemiological studies. Accid Anal Prev (2001) 1.98

Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95

Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94